FDA Approves Use Of A Cancer-Killing Virus Derived From Herpes Simplex For the first time, the FDA has approved the use of a viral therapy as an aid to fight cancer, a genetically engineered form of the herpes simplex virus. by J.E. Reich
Healthy Living/Wellness Amgen's Virus-Based Cancer Drug Wins Green Light From EU Regulators by Ted Ranosa
Healthy Living/Wellness Genetically Modified Herpes Virus Shows Promise In Fight Against Skin Cancer by Ted Ranosa
China Launches World's Largest Electric Container Ship, Slashing 8,600 Pounds of Emissions per 100 Nautical Miles